The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

Similar documents
The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Left ventricular hypertrophy: why does it happen?

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

When should you treat blood pressure in the young?

HTA ET DIALYSE DR ALAIN GUERIN

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

Dr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.

Management of early chronic kidney disease

Professor Suetonia Palmer

Special Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Optimal blood pressure targets in chronic kidney disease

Systolic Blood Pressure Intervention Trial (SPRINT)

Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention

Cardiovascular Diseases in CKD

Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Figure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis).

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George

Tread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease

Chronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US

Prof. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain.

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

AGING KIDNEY IN HIV DISEASE

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

Preventing Early Vascular Ageing (EVA) and its hemodynamic changes

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

CKD and risk management : NICE guideline

Supplementary Appendix

Actualités néphrologiques Jean Hamburger 23 Avril Marie Courbebaisse, Service de Physiologie Hôpital Européen Georges Pompidou, Paris

Structural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak

Prof. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

Stages of Chronic Kidney Disease (CKD)

The Triple Threat. Cardiac Care in the NT Annual Workshop 2017 is proudly supported by:

Protecting the heart and kidney: implications from the SHARP trial

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

The Elderly Patient with Low egfr: Beyond a Disease-Oriented Approach. Maroun Azar, M.D.

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH

SPRINT: Consequences for CKD patients

Special Lecture 10/28/2012

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K.

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

KDIGO conference on high CV risk associated with CKD. The role of BP in CKD stage 1-4

Morbidity & Mortality from Chronic Kidney Disease

Histopathology: Vascular pathology

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Chronic Kidney Disease: Optimal and Coordinated Management

Pathology of Hypertension

Chronic kidney disease-what can you do and when to refer?

CKD and CVD. Jamal Salameh, MD, FACP, FASN First Coast Nephrology

Blood Vessels. Dr. Nabila Hamdi MD, PhD

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota

Cardiovascular Protection and the RAS

Predicting and changing the future for people with CKD

Office Management of Reduced GFR Practical advice for the management of CKD

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Selected age-associated changes in the cardiovascular system

Case Studies: Renal and Urologic Impairments Workshop

Histopathology: Hypertension and diabetes in the kidney These presentations are to help you identify basic histopathological features.

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Diabetic Nephropathy

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil

Diabetes and kidney disease.

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan

Some renal vascular disorders

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

changes that occur in kidney with aging is THE MOST DRAMATIC ANY ORGAN SYSTEM.

T. Suithichaiyakul Cardiomed Chula

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Arterial function and longevity Focus on the aorta

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

KEEP 2.0 Annual Data Report Chapter Five

Kidney Disease, Hypertension and Cardiovascular Risk

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Reducing proteinuria

Chronic Kidney Disease

Prognosis in CKD Can we do anything about it? Rodney D Gilbert

So why have CKD stages I and II at all?!

Transcription:

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought. Leviticus Rabba 3 Talmud Berochoth 6 1 b

Outline & Objectives Renal sessions Identification of CKD impending epidemic? What do CKD patients die of? Why are they at a higher cardiovascular risk? Progression? egfr Real or lab changes (Sunday) Importance of proteinuria (Sunday) Combined urological session Stephen Marks. Haematuria, Kidney stones, UTIs

Chronic Kidney Disease Stage Description GFR (ml/min) 1 Kidney damage (proteinuria) with normal or increased GFR 2 Kidney damage with mild decrease in GFR 3 Moderate decrease in GFR >90 60 to 89 30 to 59 4 Severe decrease in GFR 15 to 29 5 Kidney failure < 15 or RRT

Stages of CKD a clinical continuum Kidney damage or mild reduction GFR RRT = Dialysis or transplant Proteinuria GFR >90 GFR 60-90 ml/min GFR 30-60 ml/min GFR <30 ml/min GFR ml/min S CR Stage 1 Stage 2 Stage 3 Stage 4 Stage 5

Chronic Kidney Disease (CKD) Australia or NZ Healthy Adult Community Data from AusDiab Increased risk 1:3 CKD 1:7 Dialysis or Transplant 1:1400

How much CKD in Australia? 16% of Adults >25yrs have protein or blood in urine or moderately severe reduction in kidney function* GFR <60mL/min 6.6% Albumin in urine 7.5% 2.5% Blood in Urine *MDRD based egfr

AusDiab Study- Prevalence of CKD GFR<60ml/min GFR 30-59 ml/min GFR < 30 ml/min All patients% 11.2 (8.6-13.2) 10.9(8.4-13.3) 0.3 (0.2-0.5)

Estimated 1/3 adults at increased risk of CKD AusDiab Survey April 2001 High risk subgroups: 1. Diabetes 7.5% diabetic (only ½ knew it) 23% abnormal GT 2. Hypertension 29% (only ½ knew it) 3. Smokers 23% 4. Age > 65 yrs 5. Aboriginals & Torres St Islanders (Maori and Pacific Islanders) 6. Family history of kidney disease etc 7. Obese

CKD 20 yrs to ESKD 30 yrs to ESKD

With 1:3 at risk and 1:7 with actual evidence of CKD why are so few seen with end stage kidney failure? ESKD =ESRF=RRT

CKD predicts rate of all cause death (age standardized/100 person years) HMO population 16 14 12 N=1,120,295 adults 1,120,295 adults 11.36 14.14 Rate of death 10 8 6 4 4.76 2 0.76 1.08 0 >60 45-59 30-44 15-29 <15 Estimated GFR (ml/min/1.73m 2 ) Median Follow-up = 2.8 yrs Go et al., N Engl J Med, 2004

RR Adjusted Risk Ratio showing independent and significant inverse relationships to egfr N=1,120,295 adults 1,120,295 adults 6.5 Any CVD 5.9 5.5 4.5 Adm ission Death 3.5 3.2 2.5 1.5 1 1.2 1.8 0.5 >60 45-59 30-44 15-29 <15 Median Follow-up = 2.8 yrs Go et al., N Engl J Med, 2004

Cardiovascular disease mortality by age, race, and gender in the general population and dialysis population PARFREY, P. S. et al. J Am Soc Nephrol 1999;10:1606-1615 Copyright 1999 American Society of Nephrology

Prevalence of LVH in kidney failure Renal Insufficiency General Population Mild Moderate Severe Start Dialysis CCr ml/min 75-50 50-25 <25 Prevalence LVH 17% 27% 31% 45% 75% Levin et al, AJKD 1999;34:125-134

Intramyocardial fibrosis and calcification

LV disease predicts survival on dialysis Months

Middleton & Pun Kidney Int 2010

CKD & CVD Annual CVD checks Do you assess CKD as part of this? egfr, proteinuria, hypertension

Hypertension and the Kidney

Progressive Nephropathy Initial insult seems to be followed by progressive decline. Role of loss of auto-regulation and transmission of systemic pressure to glomeruli.

Progressive Nephropathy Overall in CKD Lose the protective vasodilation or vasoconstriction Kidney senses these highs and lows in perfusion pressure Creatinine does rise and fall as you correct this (a linear relationship almost) Pre-glomerular pressure response lost and postglomerular compensation lost

Renal blood flow not protected vascular bed. Hypertension 160/96 egfr 46 ml/in 110/70 Hypotension for patient egfr 30ml/min

Arteries stiffen Long standing arterial pulsation: Medial degeneration Direct effects on matrix proteins, collagen and elastin Elastin fibres break reduplication Detachment smooth muscle fibres Increased VSMC Calcification Oxidative stress AGE add to stiffness

Thickened media Reduplication of elastic lamina Intimal hyperplasia

Arterial Stiffness: Functional changes: Reduction in endothelial mediated vasodilation Changes in smooth muscle function Note SMVC hypertrophy attempt to modify increased collagen

Age mediated changes Age mediated increases in stiffness progress more rapidly in central arteries than peripheral arteries. Increases in Aortic PWV reflect vessel stiffness Changes are independent of MAP Valid in an older age group.

Arteriosclerosis and Pulse Wave Velocity Systole Diastole

Pulse Wave Forms Shape force felt by artery. Older stiff vessel reflected wave early SBP DBP Increased pressure Heart brain kidney SE Greenwald J Pathol 2007

Impact of vascular stiffness Heart - impaired diastolic perfusion - diastolic dysfunction -additional impact of coronary calcification

Impact of vascular stiffness Heart - impaired diastolic perfusion - diastolic dysfunction -additional impact of coronary calcification Brain - increased risk stroke Kidneys - arteriolosclerosis, glomerulosclerosis

Arteriolosclerosis Interstitial fibrosis glomerulosclerosis and tubular atrophy Compensatory glomerular hypertrophy

Arteries stiffen prematurely in CKD N=467 N=680 Tomlinson L (on behalf of the UREKA collaboration) unpublished data not for distribution

Kidneys reflect vascular injury In patients with CKD Stage 3 Hypertensive nephrosclerosis is the major aetiology. Impact of proteinuria marker of endothelial injury (Sunday) Blood pressure control main focus of therapy.

Take Home Points Hypertension is a major component of Kidney disease Contributes to progression of CKD. Most patients with CKD die of CVD 10 20 x risk of CV event Proteinuria and hypertension are major prognostic factors require more aggressive treatment. Frequently require 3 drug therapy drug type.

Once in a while You may come across a place where everything is as close to perfection as you will ever need Place Brian Turner Old age is a disease which we can not cure. Seneca (c. 4 BC - 65 AD)